Cargando…

Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study

Proton pump inhibitor (PPI) twice daily dosing is a standard therapy for gastroesophageal reflux disease (GERD) in systemic sclerosis (SSc) but there is no data on its response rate or the predictors of PPI-partial response GERD. Aims were to determine the prevalence of PPI-partial response GERD in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foocharoen, Chingching, Chunlertrith, Kitti, Mairiang, Pisaln, Mahakkanukrauh, Ajanee, Suwannaroj, Siraphop, Namvijit, Suwassa, Wantha, Orathai, Nanagara, Ratanavadee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972652/ https://www.ncbi.nlm.nih.gov/pubmed/31964957 http://dx.doi.org/10.1038/s41598-020-57636-0

Ejemplares similares

Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis
por: Mahakkanukrauh, Ajanee, et al.
Publicado: (2020)

Skin thickness affects the result of tuberculin skin test in systemic sclerosis
por: So-ngern, Apichart, et al.
Publicado: (2022)

Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis
por: Chuealee, Wiriya, et al.
Publicado: (2021)

Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study
por: Pussadhamma, Burabha, et al.
Publicado: (2020)

The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients
por: Paolee, Yathao, et al.
Publicado: (2021)

Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis
por: Laovirojjanakul, Wipada, et al.
Publicado: (2022)

Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis
por: Sumphao-Ngern, Pichaporn, et al.
Publicado: (2015)

Prevalence of erectile dysfunction in Thai scleroderma patients and associated factors
por: Sirithanaphol, Wichien, et al.
Publicado: (2023)

Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database
por: Foocharoen, Chingching, et al.
Publicado: (2021)

Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis
por: Pongkulkiat, Patnarin, et al.
Publicado: (2022)

Incidence and Prevalence of Septic Arthritis in Thailand: A Database from the Ministry of Public Health
por: Foocharoen, Thanit, et al.
Publicado: (2023)

Sleep quality and clinical association with sleep disturbance in systemic sclerosis
por: Wongthawa, Nonthaphorn, et al.
Publicado: (2023)

Development and validation of machine learning for early mortality in systemic sclerosis
por: Foocharoen, Chingching, et al.
Publicado: (2022)

Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis
por: Sangaroon, Arthitaya, et al.
Publicado: (2022)

Incidence and prevalence of systemic sclerosis in Thailand in year 2017–2020: a database from the Ministry of Public Health
por: Foocharoen, Chingching, et al.
Publicado: (2023)

Low prevalence of contraceptive counseling at Srinagarind hospital, Thailand among women of reproductive age with systemic lupus erythematosus
por: Kittisiam, Thannaporn, et al.
Publicado: (2013)

Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis
por: Wongjirattikarn, Rachot, et al.
Publicado: (2020)

Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study
por: Sawadpanich, Kookwan, et al.
Publicado: (2023)

Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
por: Kuipers, E. J., et al.
Publicado: (1999)

Thailand guideline 2020 for medical management of gastroesophageal reflux disease
por: Maneerattanaporn, Monthira, et al.
Publicado: (2022)

Comparison of Gastroesophageal Reflux Disease Symptoms and Proton Pump Inhibitor Response Using Gastroesophageal Reflux Disease Impact Scale Questionnaire
por: Jo, So Young, et al.
Publicado: (2013)

Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
por: Mermelstein, Joseph, et al.
Publicado: (2018)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
por: Sung, Hea Jung, et al.
Publicado: (2012)

Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?
por: Belei, Oana, et al.
Publicado: (2018)

Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
por: Tariq, Muhammad Ali, et al.
Publicado: (2022)

Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
por: Shi, Yichao, et al.
Publicado: (2023)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
por: Fossmark, Reidar, et al.
Publicado: (2023)

Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018)

Complete Resolution of Pseudomalignant Erosion in a Reflux Gastroesophageal Polyp with Proton Pump Inhibitor
por: Nakajima, Takahiko, et al.
Publicado: (2015)

Predictive Factors of Response to Proton Pump Inhibitors in Korean Patients With Gastroesophageal Reflux Disease
por: Kim, Sung Eun, et al.
Publicado: (2015)

Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children
por: Malaty, Hoda M, et al.
Publicado: (2009)

Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
por: de Sá, Cláudia Cristina, et al.
Publicado: (2011)

Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015)

Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease
por: Zheng, Connor L, et al.
Publicado: (2018)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

Is the Diagnostic Trial with Proton Pump Inhibitors Reasonable for School Age Children with Gastroesophageal Reflux Symptoms?
por: Yang, Jaeeun, et al.
Publicado: (2019)

Effect of a Preoperative Proton Pump Inhibitor and Gastroesophageal Reflux Disease on Postoperative Nausea and Vomiting
por: Kwon, Young Suk, et al.
Publicado: (2020)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nqagdo06u8nfo092nlmm6369if